Lipocine Inc. (LPCN)
NASDAQ·Healthcare·Biotechnology
$1.63
+3.61%
Mkt Cap $11.87M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+268.1%
Consensus $6.00 vs current $1.63
NASDAQ·Healthcare·Biotechnology
$1.63
+3.61%
Mkt Cap $11.87M
Buy
0
Hold
1
Sell
0
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
+268.1%
Consensus $6.00 vs current $1.63